Fetal striatal tissue transplants have been shown to restore motor deficits in rat and monkey models of Huntington's disease (HD). In the present study, using rats with unilateral striatal lesions, we compared fetal striatal tissue transplants to transplants of human NT (hNT) neurons. hNT neurons are terminally differenti ated cells derived from the human NTera-2 cell line. In vitro, we have found that purified hNT neurons have a biochemical phenotype similar to that of human fetal striatal tissue. Both hNT neurons and fetal striatal tissue express mRNAs for glutamic acid decarboxylase, choline acetyltransferase, and the D, and D 2 dopa mine receptors. Grafts of either hNT neurons or fetal striatal tissue into unilateral quinolinic acid-lesioned rat striatum improved methamphetamine-induced circling behavior. Sham controls showed no changes in methamphetamine-induced circling behavior. In the staircase test for skilled forelimb use, both transplant groups showed partial recovery in skilled use of the paw contralateral to the side of lesion, whereas the control animals showed continued deficits. These findings suggest that transplantation of hNT neurons may be an alternative to transplantation of fetal striatal tissue in the treatment of HD.
INTRODUCTION
Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder resulting from triplet CAG expansion (polyglutamine expansion) in the gene for huntingtin protein on chromosome 4 (17) . The disease is characterized by severe neuronal degeneration primar ily in the corpus striatum (caudate nucleus, putamen, and globus pallidus) and, to a lesser extent, in other brain regions (40) . The symptoms associated with HD include movement abnormalities such as chorea and dystonia, affective disorders, and cognitive impairment. Psychiatric symptoms most often present as depression and irritability. The cognitive deficit of HD is subcorti cal dementia (15) . In animals, excitotoxic lesions in duced by injection of glutamate receptor agonists into the striatum can mimic the neuronal degeneration and motor disorder observed in HD (5, 34, 35) .
Following promising results in animals, implantation of fetal brain tissue has been used to treat patients with neurodegenerative diseases. Fetal mesencephalic im plants have been effective in reducing behavioral defi cits in animal models of Parkinson's disease (PD) (3) and have improved symptoms in PD patients (10-13, 23,24,41) . Similarly, neural transplants of fetal or new born striatal tissue have been shown to correct motor deficits and biochemical abnormalities in HD animal models (7, 9, 18, 19, 21, 28, 38) . The first clinical studies implanting fetal tissue into HD patients are now being performed (25, 31) . The pharmacological treatment of HD with drugs like dopamine receptor antagonists pro vides only partial symptom relief. Neural transplantation offers the hope of a treatment for HD with the potential to improve quality of life and increase life expectancy.
A major limitation of neural transplantation is the present need to acquire human neural tissue from in duced abortions. In addition to social and ethical issues, it is difficult to recover appropriate fetal brain tissue.
To circumvent these problems, many groups are seeking alternatives to human fetal tissue. A human teratocarcinoma cell line, NTera 2/D1, can terminally differentiate into neurons when treated with retinoic acid (32) . These differentiated cells, called hNT neurons, have survived neurotransplantation for at least 1 year in nude mice (22, 29) and for at least 3 months in primates (C. R. Freed, unpublished data) without tumor formation. After establishing that hNT neurons express both GABAergic and cholinergic phenotypes characteristic of intrinsic striatal neurons, we postulated that hNT neurons might function as an alternative to fetal striatal tissue for trans plantation into an animal model of HD. hGAD 65  forward  5'-GGCTCTGGCTTTTGGTCTTTC-3'  reverse  5'-TGCCAATTCCCAATTATATTCTTGG-3'  hGAD 67 forward
by destroying striatum with injection of excitotoxic glu tamate analogues (5, 6, 26, 27, 34, 35) . Quinolinic acid, a more selective excitotoxin derived endogenously from tryptophan, produces a lesion that more closely mimics the neuronal loss of HD by sparing subsets of neurons, such as NADPH diaphorase, somatostatin, and neuro peptide Y positive neurons (1, 2, 37) . Animals with extensive excitotoxic lesions of the striatum show dopamine-dependent circling behavior. Systemic administra tion of dopaminergic agents such as apomorphine or methamphetamine results in circling behavior ipsilateral to the lesioned side (9, 36) . In addition, lesioned animals have deficits in skilled use of the paw contralateral to the lesioned side as determined in the staircase test (30, 42) . In our study, we compared hNT neurons to fetal striatal tissue for their ability to correct the behavioral abnormalities induced by unilateral quinolinic acid le sions of rat striatum.
MATERIALS AND METHODS

In Vitro Characterization of hNT Neurons
hNT neurons, provided by Layton Bioscience, Inc. (Gilroy, CA), were cultured in DMEM supplemented with 10% FBS. Cells were differentiated by exposure to 10 (xM retinoic acid (RA) for 5 weeks. Following RA treatment, cells were passaged 1:6 and treated for 7 days with a mixture of antimitotic agents (1 uM cytosine arabinoside, 10 uM fluorodeoxyuridine, and 10 |iM uri dine). Differentiated hNT neurons were separated from the underlying accessory cell layer.
To assess neurotransmitter phenotype by RT-PCR, total RNA was collected from purified hNT neurons in culture or from freshly dissected human fetal striatum (6-8 weeks postconception) using RNeasy Total RNA isolation kit (Qiagen). Human fetal tissue was obtained from elective abortions with women giving informed consent to research use of the tissue. All state and fed eral laws were followed. Total RNA (1 pg) was reverse transcribed (RT) using MuLV reverse transcriptase (Perkin-Elmer). One tenth of the RT reaction was used as a template in the polymerase chain reaction (PCR). The conditions for the PCR were as follows: denaturation (96°C, 40 s), annealing (60°C, 40 s), and elongation (72°C, 60 s), 25 cycles, using a Perkin-Elmer 9600 Cy cler. A trace amount of [oc-32 P]dCTP (1.5 u.Ci) was added to each of the reactions. The primers used for PCR are listed in Table 1 . All primers were purchased from Gibco BRL Custom Primers (Grand Island, NY) except for the G3PDH primers, which were purchased from Clonetech (Palo Alto, CA). Each PCR product was subjected to electrophoresis using a 6% Tris-borate polyacrylamide gel and the dried gel was exposed to a phosphorimage screen. The phosphorimage screen was analyzed using Molecular Analyst imaging software and the GS250 Molecular Imager (BioRad, Hercules, CA).
For immunocytochemistry, hNT cultures were fixed with 4% paraformaldehyde, and endogenous peroxidase activity blocked with 3% H 2 0 2 (v/v) and 10% methanol (v/v) in a 100 mM Tris-HCl, 150 mM NaCl buffer, pH 7.4. Samples were rinsed three times with Tris buffer and blocked for nonspecific binding with 10% goat se rum for 1 h at 37°C, and incubated overnight at room temperature with monoclonal anti-human choline acetyltransferase (at 1:1000, Boehringer Mannheim, Indianap olis, IN) or polyclonal anti-glutamate decarboxylase an tibodies (at 1:500, Chemicon, Temecula, CA). Immunoreactivity for either antigen was visualized with peroxidase using Vectastain (Vector Laboratories, Burlingame, CA).
Animal Lesions and Behavioral Testing
Lesion and transplant procedures were performed ste- napolis, IN) were injected with 1 ul over 5 min of 300 nmol quinolinic acid (QA) into the left striatum (AP: 0.0, L: +2.4, from bregma; V: -5.6, from dura). Four weeks later, the lesion procedure was repeated at a sec ond, more lateral site in the left striatum (AP: +0.5, L: +4.2, V: -5.6, from dura). The lesion coordinates at dual sites in the striatum were selected based on the recent report by Flicker and colleagues who found lesions at these sites yield reproducible drug-induced circling (14) . Two weeks following the second lesion, animals were screened for successful lesions by measuring circling rate in response to methamphetamine (5.0 mg/kg, IP) and apomorphine (1.0 mg/kg, SC), and for skilled motor use in the staircase test (9, 30, 42) . Animals were tested for rotation rate, as described previously, in a flat-bed rotometer system used in our laboratory (33) . In the staircase test for skilled motor use, animals were tested prior to lesioning for left-right bias. No left-right bias was observed. The skilled paw testing procedure was carried out over 20 days. Animals were food deprived for 2 h prior to testing. Animals were then placed in the staircase apparatus for 15 min daily. The first 5 days were for training purposes and data on skilled paw reaching were recorded from the last 15 days of testing. Transplantation groups were balanced for their circling response to methamphetamine by alternately assigning animals to each of the three treatment groups in the rank order of circling. The average circling rate after adminis tration of methamphetamine for each group was thus 6.5 rotations per minute (rpm) over the 90-min test period. Animals were tested for methamphetamine-and apomorphine-induced circling behavior, at 4, 8, and 12 weeks posttransplantation. At weeks 10 through 12 post transplantation, animals were tested for skilled paw use in the staircase test.
Neurotransplantation
Four weeks after establishing behavioral deficits, le sioned animals received intrastriatal transplants of 0.5 x 10 6 hNT neurons (either freshly prepared or from cryo preserved stocks) or 1.0 x 10 6 ED 15 embryonic rat stria tal cells in suspension, or vehicle injection in 3 ul vol ume into each of two sites (AP: 0.0 and 0.5, L: 2.9 and 3.7, from bregma; V: -6.5 to -3.5, from dura). To pre vent rejection of the xenograft human hNT neurons, rats were treated with cyclosporine (10 mg/kg/day, SC). Cyclosporine treatment started 48 h prior to transplanta tion and was continued daily until the conclusion of the experiment.
Histochemical Assessment
At 12 weeks after transplantation, animals were anes thetized with chloral hydrate (400 mg/kg) and intracardially perfused with cold heparinized saline followed by Brain sections were incubated overnight at room temper ature with monoclonal antibodies for DARPP-32 (at 1: 10,000; the antibody was a gift from Dr. Hugh Hemmings, Cornell Medical Center). The antibody-antigen interaction was visualized using biotinylated anti-mouse IgG (Calbiochem, CA) followed by peroxidase-diaminobenzidene using Vectastain kit (Vector Laboratories Inc., Burlingame, CA). The mass of the grafts was deter mined by scanning and analyzing sections with NIH-Image 1.57 image analysis software (Wayne Rasband, NIMH) on a Power Macintosh 8100/110 personal com puter coupled to a slide scanner (Coolscan, Nikon).
RESULTS
In Vitro Characterization
RT-PCR showed that differentiated hNT neurons and human embryonic striatum express mRNAs for enzymes in the synthetic pathways of the neurotransmitters GABA and acetylcholine (Fig. 1) . We found both hNT neurons and human fetal striatal tissue express two isoforms of glutamic acid decarboxylase, GAD 65 and GAD 67, as well as choline acetyltransferase (ChAT), and the dopamine D, and D 2 receptors. The double bands seen in the GAD 67 PCR products represent alter natively spliced transcripts, GAD 67 and EP10, both of which code for functional enzyme (39) . The hNT neu rons appear to express lower levels of the synthetic en zymes GAD and ChAT mRNA, and higher levels of Di and D 2 dopamine receptor mRNA compared to the hu man fetal striatal tissue tested in these experiments. Ad ditionally, hNT neurons in culture express GAD and ChAT proteins as shown by immunocytochemistry ( Fig.  IB and C) .
Behavioral Effects
Quinolinic acid-induced lesions of the striatum re sulted in circling ipsilateral to the lesion in response to methamphetamine (5.0 mg/kg, IP) and apomorphine (1.0 mg/kg, SC). Intrastriatal grafts of either embryonic stria tal tissue or hNT neurons improved drug-induced cir cling behavior. Prior to transplantation, lesioned animals circled at 6.5 ± 0.4 rpm in response to methamphetamine and 4.1 ± 0.2 rpm in response to apomorphine. Animals that received hNT neuron or fetal striatal tissue trans plants required 8 weeks to show behavioral recovery in the drug-induced circling tests (data not shown). By 12 weeks posttransplantation, methamphetamine-induced circling slowed to 4.0 ± 1.4 rpm in animals transplanted with fetal striatal tissue, a 40% reduction from pregrafting baseline (/><0.01, Student-Newman-Keuls, Fig.  2A ). For animals transplanted with hNT neurons, cir cling was reduced to 3.3 ± 0.4 rpm, a 50% reduction from baseline (p < 0.01, Fig. 2A ). There was no signifi cant improvement in apomorphine-induced circling for either transplant group. Although circling appeared to slow 35% compared to pretransplantation baseline for both hNT neuron and striatal transplant groups, large interanimal variation made the data not statistically dif ferent from baseline (Fig. 2B ). Sham-transplanted ani mals showed no change in circling behavior induced by either drug ( Fig. 2A and B) .
In the staircase test for skilled paw use, all lesioned animals showed deficits in use of the paw contralateral to the side of lesion prior to transplantation. At 10 weeks posttransplantation, skilled use of the contralateral paw improved in animals that received grafts of hNT neurons and fetal striatal tissue (Fig. 3) . By contrast, sham-trans planted animals showed continued deterioration in use of the contralateral paw.
Histological Assessment
The extent of the lesion induced by QA injection was determined in all animals. Consecutive brain sections were cut in the coronal plane and histochemically stained for Nissl bodies using cresyl violet. Analysis re vealed that QA induced a massive loss of the corpus striatum ( Fig. 4) . In many animals, the lesion also ex tended to the cortex (frontal and temporal). Despite this severe lesion, destruction by QA was primarily confined to the striatum with some damage to adjacent cortex but not to globus pallidus, thalamus, or brain stem regions. Of the two transplant tracts we had placed in each ani mal, only the lateral tract was seen because the medial tract coordinates had targeted the fluid space of an en larged ventricle due to the massive cell loss induced by the lesion. The transplanted fetal striatal neurons were immunoreactive for DARPP-32, whereas the trans planted hNT neurons were not ( Fig. 4A and B) . The hNT transplants were easily recognized by immunostaining for DARPP-32 to visualize remaining endoge nous striatum followed by counterstaining of neurons for Nissl substance. The hNT neurons were those not stained by the DARPP-32 (Fig. 4A) .
The volume of the grafts of fetal striatum and hNT neurons was calculated for each animal by measuring the areas of each transplant section and combining those areas for consecutive coronal brain sections and multi plying by the separation of the sections. Results showed that the average volume of the striatal transplants was 2.6 mm 3 and of hNT transplants it was 0.5 mm 3 . Thus, the striatal transplant volume was about fivefold larger than the hNT transplant volume. The differences in graft size between the two groups were expected given that half as many hNT neurons were transplanted. Addition ally, hNT neurons, unlike striatal cells, are postmitotic and will not divide in vivo.
DISCUSSION
Using quinolinic acid we have induced a relatively large striatal lesion with neuronal degeneration similar to HD. Lesioned animals showed reproducible ipsilateral circling to methamphetamine and apomorphine. They also had deficits in using the contralateral paw for skilled motor tasks. We found that transplants of differ entiated hNT neurons from the teratocarcinoma cell line, NTera 2/D1, can partially reverse both the drug-induced and skilled motor deficits. The hNT neuron transplants were equivalent to fetal striatal transplants in their be havioral effects.
The similarities in neurochemical phenotype of hNT neurons and fetal striatal tissue are substantial. These similarities are the likely reason that transplantation of hNT neurons yields behavioral recovery similar to trans plantation of embryonic striatal tissue. As we have shown, hNT neurons have the synthetic enzymes to make GABA and acetylcholine, as well as D! and D 2 dopamine receptors. Expression of all these attributes could allow these cells to mimic intrinsic striatal cell function. We suspect that the expression of D] and D 2 dopamine receptors in the hNT neurons may be impor- tant because others have found expression of these recep tors on transplanted tissue was necessary for behavioral recovery (8, 16) . On the other hand, hNT neurons failed to express DARPP-32 as shown by lack of immunostaining with the DARPP-32 antibody. This result demon strates that these cells are not identical to striatal neurons.
The time course of behavioral recovery observed in our study is similar to previous reports using fetal cell transplants in HD animal models. Both hNT neurons and fetal striatal cell transplants require 8 to 12 weeks to show a behavioral effect, suggesting that the hNT neu rons, like embryonic striatal cells, require neural connec tivity prior to behavioral recovery. Others have shown that transplantation of ED 13-15 striatal cell suspensions into rats with unilateral striatal lesions produced func tional recovery in hypermetabolic responses by 10 weeks posttransplantation as measured by 2-deoxy[ 14 C]glucose (18) . In rats with bilateral ibotenic acid lesions, overnight locomotor hyperactivity was completely com pensated for by intrastriatal fetal striatal implants by 10-15 weeks posttransplantation (20) . In a longer term study, Dunnett et al. (9) showed progressive reduction in both methamphetamine-and apomorphine-induced circling and greater recovery in skilled use of both paws in the staircase test at 7 months posttransplantation of embryonic striatal tissue. We speculate that longer fol low-up of animals with hNT neural transplants might produce greater behavioral improvement.
hNT neurons have proven useful for transplantation in other neuropathologic conditions. When transplanted into an ischemic stroke model in the rat, hNT neurons restored mental function and limb usage (4) . Recently, hNT neurons (designated as LBS to signify they were manufactured for human transplant use) were trans planted into a human patient who had suffered a throm botic stroke 6 months prior to the transplant. No results of that intervention are available.
Given the difficulties in obtaining sufficient quanti ties of uniform quality human embryonic brain tissue for neural transplantation, there is a need for alternative sources of neural tissue for therapeutic transplantation. We have shown that hNT neurons may be a useful alter native to fetal striatal tissue for neural transplantation treatment of Huntington's disease.
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